Rebound, a B2B marketing and commercial accelerator for technology and data companies in life sciences and healthcare, has been recognized on the prestigious Inc. 5000 list as one of America’s fastest-growing private companies for the second consecutive year.
Rebound’s CEO, Meridith Rohrbaugh and Senior Partner, Bob Harrell, speak with MM+M about how managing the three T’s of talent, transparency and team can change the trajectory of revenue and growth.
Rebound Senior Partner, Bob Harrell, contributes to PharmaLive with his view on the trends impacting pharma marketing, including the rise of ChatGPT, in 2023 and beyond.
Rebound’s General Manager of Strategy & Product Marketing, Rich Glew, details for PharmaLive how our model of Commercial Acceleration works for life sciences companies.
Rebound Founder and CEO, Meridith Rohrbaugh, explains in PharmaLive the 6 ways life science tech brands can strengthen their product marketing and customer communication efforts.
Rebound’s Commercial Acceleration Model was named one of the Most Innovative Strategies of the last year by PM360. Learn more about our approach that is helping life sciences tech and data companies achieve better results faster.
Rebound has been recognized on the prestigious Inc. 5000 annual list of the fastest-growing private companies in America.
Subscribe to our newsletter!
Join Our Newsletter for Exclusive Updates and Insights.
ReboundB2B
Rebound is a strategic partner with the comprehensive capabilities needed to drive commercial performance and accelerate growth for companies developing technology and data solutions for the life sciences industry.
Read about Rebound and how we have strategically partnered with businesses to accelerate commercial performance, increase growth, and increase valuations.